Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Identification of ferroportin disease in the Indian subcontinent.

Literature DB >> 15753550

Identification of ferroportin disease in the Indian subcontinent.

D F Wallace, P Browett, P Wong, H Kua, R Ameratunga, V N Subramaniam.

Abstract

Mesh：

Substances：

Year: 2005 PMID： 15753550 PMCID： PMC1774468 DOI： 10.1136/gut.2004.060988

Source DB: PubMed Journal: Gut ISSN： 0017-5749 Impact factor: 23.059

× No keyword cloud information.

9 in total

Review 1. Non-HFE hemochromatosis.

Authors: Antonello Pietrangelo
Journal: Hepatology Date: 2004-01 Impact factor: 17.425

2. A valine deletion of ferroportin 1: a common mutation in hemochromastosis type 4.

Authors: Antonella Roetto; Alison T Merryweather-Clarke; Filomena Daraio; Karen Livesey; Jennifer J Pointon; Giuliana Barbabietola; Antonio Piga; Peter H Mackie; Kathryn J H Robson; Clara Camaschella
Journal: Blood Date: 2002-07-15 Impact factor: 22.113

3. A novel MHC class I-like gene is mutated in patients with hereditary haemochromatosis.

Authors: J N Feder; A Gnirke; W Thomas; Z Tsuchihashi; D A Ruddy; A Basava; F Dormishian; R Domingo; M C Ellis; A Fullan; L M Hinton; N L Jones; B E Kimmel; G S Kronmal; P Lauer; V K Lee; D B Loeb; F A Mapa; E McClelland; N C Meyer; G A Mintier; N Moeller; T Moore; E Morikang; C E Prass; L Quintana; S M Starnes; R C Schatzman; K J Brunke; D T Drayna; N J Risch; B R Bacon; R K Wolff
Journal: Nat Genet Date: 1996-08 Impact factor: 38.330

4. Genetic hyperferritinaemia and reticuloendothelial iron overload associated with a three base pair deletion in the coding region of the ferroportin gene (SLC11A3).

Authors: Mario Cazzola; Laura Cremonesi; Maria Papaioannou; Nadia Soriani; Anna Kioumi; Anastasia Charalambidou; Rita Paroni; Katerina Romtsou; Sonia Levi; Maurizio Ferrari; Paolo Arosio; John Christakis
Journal: Br J Haematol Date: 2002-11 Impact factor: 6.998

5. Absence of hemochromatosis associated Cys282Tyr HFE gene mutation and low frequency of hemochromatosis phenotype in nonalcoholic chronic liver disease patients in India.

Authors: V Thakur; R C Guptan; A Z Hashmi; P Sakhuja; V Malhotra; S K Sarin
Journal: J Gastroenterol Hepatol Date: 2004-01 Impact factor: 4.029

6. Autosomal dominant reticuloendothelial iron overload associated with a 3-base pair deletion in the ferroportin 1 gene (SLC11A3).

Authors: Vinod Devalia; Kymberley Carter; Ann P Walker; Stephen J Perkins; Mark Worwood; Alison May; James S Dooley
Journal: Blood Date: 2002-07-15 Impact factor: 22.113

7. Novel mutation in ferroportin1 is associated with autosomal dominant hemochromatosis.

Authors: Daniel F Wallace; Palle Pedersen; Jeannette L Dixon; Peter Stephenson; Jeffrey W Searle; Lawrie W Powell; V Nathan Subramaniam
Journal: Blood Date: 2002-07-15 Impact factor: 22.113

8. Distribution of C282Y and H63D mutations in the HFE gene in healthy Asian Indians and patients with thalassaemia major.

Authors: Gurvinder Kaur; C Chen Rapthap; M Xavier; R Saxena; V P Choudhary; S K Reuben; N K Mehra
Journal: Natl Med J India Date: 2003 Nov-Dec Impact factor: 0.537

Review 9. The ferroportin disease.

Authors: Antonello Pietrangelo
Journal: Blood Cells Mol Dis Date: 2004 Jan-Feb Impact factor: 3.039

9 in total

7 in total

1. Ferroportin disease due to the A77D mutation in Australia.

Authors: V N Subramaniam; D F Wallace; J L Dixon; L M Fletcher; D H Crawford
Journal: Gut Date: 2005-07 Impact factor: 23.059

Review 2. Non-HFE haemochromatosis.

Authors: Daniel-F Wallace; V-Nathan Subramaniam
Journal: World J Gastroenterol Date: 2007-09-21 Impact factor: 5.742

Review 3. Ethnic Differences in Iron Status.

Authors: Wanhui Kang; Alexa Barad; Andrew G Clark; Yiqin Wang; Xu Lin; Zhenglong Gu; Kimberly O O'Brien
Journal: Adv Nutr Date: 2021-10-01 Impact factor: 8.701

Review 7. Twenty Years of Ferroportin Disease: A Review or An Update of Published Clinical, Biochemical, Molecular, and Functional Features.

Authors: L Tom Vlasveld; Roel Janssen; Edouard Bardou-Jacquet; Hanka Venselaar; Houda Hamdi-Roze; Hal Drakesmith; Dorine W Swinkels
Journal: Pharmaceuticals (Basel) Date: 2019-09-09